SCHEMBL14907404

SCHEMBL14907404

CCOC(=O)c1ncc(CC)cc1N

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.43
CYP1A2 P05177 2/20 0.43
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
HSD17B10 Q99714 2/20 0.42
MAPK1 P28482 2/20 0.42
GAA P10253 1/20 0.42
GABRA1 P14867 2/20 0.41
GABRG2 P18507 2/20 0.41
GABRB3 P28472 2/20 0.41
GABRA5 P31644 2/20 0.41
GABRA3 P34903 2/20 0.41
GABRA2 P47869 2/20 0.41
GABRA6 Q16445 1/20 0.41
HSP90AA1 P07900 1/20 0.41
LMNA P02545 1/20 0.41
CYP3A4 P08684 1/20 0.41
MAOA P21397 1/20 0.41
HTT P42858 2/20 0.41
CYP2C9 P11712 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13622778 0.85 ALDH1A1 (0.44) ALDH1A1CYP1A2MEN1KMT2AHSD17B10
SCHEMBL24131085 0.85 CYP1A2 (0.46) ALDH1A1CYP1A2MEN1KMT2AHSD17B10
SCHEMBL5540834 0.84 ALDH1A1 (0.46) ALDH1A1CYP1A2MEN1KMT2AHSD17B10
SCHEMBL9586331 0.83 GABRA1 (0.46) ALDH1A1CYP1A2HSD17B10MAPK1GABRA1
SCHEMBL8692342 0.83 ALDH1A1 (0.46) ALDH1A1CYP1A2MEN1KMT2AHSD17B10
SCHEMBL16663609 0.83 KDM4E (0.44) ALDH1A1CYP1A2MEN1KMT2AHSD17B10
SCHEMBL4584766 0.82 MAPT (0.45) ALDH1A1MEN1KMT2AMAPK1GABRA2
SCHEMBL6559833 0.82 TSHR (0.46) ALDH1A1MEN1KMT2AMAPK1GAA
SCHEMBL29897883 0.82 TSHR (0.46) ALDH1A1MEN1KMT2AMAPK1GAA
SCHEMBL14895377 0.80 RAB9A (0.42) ALDH1A1CYP1A2MEN1KMT2AHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013060881-A1 PYRIDOPYRIMIDINES AND THEIR THERAPEUTIC USE VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS, WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG (NL) 2013-05-02 WO disclosed